Browse by author
Lookup NU author(s): Dr Rachel Oldershaw
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
We report a chemically defined, efficient, scalable and reproducible protocol for differentiation of human embryonic stem cells (hESCs) toward chondrocytes. HESCs are directed through intermediate developmental stages using substrates of known matrix proteins and chemically defined media supplemented with exogenous growth factors. Gene expression analysis suggests that the hESCs progress through primitive streak or mesendoderm to mesoderm, before differentiating into a chondrocytic culture comprising cell aggregates. At this final stage, 74% (HUES1 cells) and up to 95ĝ€"97% (HUES7 and HUES8 cells) express the chondrogenic transcription factor SOX9. The cell aggregates also express cell surface CD44 and aggrecan and deposit a sulfated glycosaminoglycan and cartilage-specific collagen II matrix, but show very low or no expression of genes and proteins associated with nontarget cell types. Our protocol should facilitate studies of chondrocyte differentiation and of cell replacement therapies for cartilage repair. © 2010 Nature America, Inc. All rights reserved.
Author(s): Oldershaw R, Baxter M, Lowe E, Bates N, Grady L, Soncin F, Brison D, Hardingham T, Kimber S
Publication type: Article
Publication status: Published
Journal: Nature Biotechnology
Year: 2010
Volume: 28
Issue: 11
Pages: 1187-1194
Print publication date: 22/10/2010
ISSN (print): 1087-0156
ISSN (electronic): 1546-1696
Publisher: Nature Publishing Group
URL: http://dx.doi.org/10.1038/nbt.1683
DOI: 10.1038/nbt.1683
Altmetrics provided by Altmetric